Neuros Medical
neurosmedical.com
Health & Medical Electronics
Financial Services
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$138M
7 rounds on record
Latest round
$56M
Series D · Jul 2025 · 15 mo ago
Team
48
US Form 5500 (plan participants) · Dec 2025 · +14% in a year
Backers
1
USVP
The money's age
Due for its next round
15 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 23
New executive Neuros Medical Appoints Thomas Tovello as Chief Financial Officer · morningstar.com
Jul 9, 2025
Certified Neuros Medical Secures $56M Series D to Commercialize the Altius System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputa… · YahooFinance
Jul 9, 2025
Raised a round Series D $56M · SEC Form D
Jun 16, 2023
Raised a round Venture round $20M · SEC Form D
Nov 15, 2022
Took on debt financing $8.2M · SEC Form D
Oct 27, 2020
Raised a round Venture round $37M · SEC Form D
May 27, 2020
Took on debt financing $2.2M · SEC Form D
Oct 11, 2019
Raised a round Venture round $2.4M · SEC Form D
Aug 3, 2017
Raised a round Venture round $22.6M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series D | Jul 2025 | $56M | — | SEC Form D |
| Venture round | Jun 2023 | $20M | — | SEC Form D |
| Debt Financing | Nov 2022 | $8.2M | — | SEC Form D |
| Venture round | Oct 2020 | $37M | — | SEC Form D |
| Debt Financing | May 2020 | $2.2M | — | SEC Form D |
| Venture round | Oct 2019 | $2.4M | — | SEC Form D |
| Venture round | Aug 2017 | $22.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Neuros Medical, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Robert CentaExecutive OfficerSEC Form D
Jon SnyderExecutive Officer, DirectorSEC Form D
Thomas WilderExecutive Officer, DirectorSEC Form D
David VeinoExecutive Officer, DirectorSEC Form D
Zach StassenExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
USVP Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Cagent Vascular pioneers Serration Remodeling Therapy (SRT) creating controlled lines of weakness to release the internal elastic lamina…
OrthoPulse® is the first and only approved medical device that uses near infrared light technology to shorten treatment time and reduce…
Cincinnati-based surgical procedure company focused on innovative development, commercialization of medical devices for treatment of…
There are over 60 million people with heart failure worldwide. It is the leading cause of hospitalization in people over 65.
0 ABOUT US Advancing Patient Care with Cutting-Edge Technology At Nventric, we are driving innovation in medical technology to transform…
Noleus Technologies is developing a novel medical device to reduce patient complications following abdominal surgery.
News
Neuros Medical: $56 Million Series D Closed For Non-Opioid Pain Treatment
Neuros Medical, the maker of the FDA-approved Altius Direct Electrical Nerve Stimulation System for chronic post-amputation pain, announced an oversubscribed $56 million Series D financing round. The funding, led by EQT Life Sciences with participation fr
Read more
Report
Neuros Medical Secures $56M Series D to Commercialize the Altius System, an FDA-Approved, Non-Opioid Nerve Stimulation System for Chronic Post-Amputation Pain
Neuros Medical, Inc., the maker of the Altius Direct Electrical Nerve Stimulation System, an FDA-approved, breakthrough non-opioid treatment for chronic post-amputation pain, today announced the closing of an oversubscribed $56 million Series D financing
Read more
Report
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing! The post Hello world! appeared first on Neuros Medical.
Read more
Report
Neuros Medical is raising $42.8 million
The Willoughby Hills firm is developing a patented therapy for the treatment of chronic, post-amputation pain with a high-frequency electrical signal.
Read more
Report
Neuros Medical Adds Vice President of Clinical and Regulatory Affairs to Management Team
CLEVELAND---- Neuros Medical, Inc., a medical device company, today announced the addition of Joe Schwoebel to their management team as Vice President, Clinical and Regulatory Affairs.
Read more
Report
Fresh from fundraising, Neuros Medical hires chief technology officer, appoints clinical advisers
Fresh from its first round of fundraising, neurostimulation device developer Neuros Medical Inc. has hired a chief technology officer and appointed a board of advisers.
Read more
Report
People
Robert Centa
Executive Officer
Jon Snyder
Executive Officer, Director
Thomas Wilder
Executive Officer, Director
David Veino
Executive Officer, Director
Zach Stassen
Executive Officer
Claiborne Rankin
Director
Joseph Jankowski
Director
Scott Drees
Director
Stephen Haynes
Director
Anthony Natale
Director
William Harrington
Director
Casey Tansey
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Willoughby Hills
United States
HQ
Arden Hills
United States
Regional office
Mailing Address
1212 Red Fox Rd, Arden Hills, MN 55112
Financials
Total raised
$148.4M
Latest round
Series D
Funding rounds
7
Funding rounds